[1]
2022. Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?. Bleeding, Thrombosis and Vascular Biology. 1, 1 (Apr. 2022). DOI:https://doi.org/10.4081/btvb.2022.22.